Literature DB >> 27591814

Use of intrauterine devices in nulliparous women.

Patricia A Lohr1, Richard Lyus2, Sarah Prager3.   

Abstract

Five intrauterine devices (IUDs) are available in the United States: four levonorgestrel-releasing intrauterine systems (two containing 52 mg, one containing 19.5 mg and one containing 13.5 mg) and one copper-bearing device (Copper T 380A). All IUDs have very low typical-use failure rates and high acceptability ratings, yet they are used by a minority of women, with nulliparous women less likely to do so than parous women. The objective of this clinical review is to give evidence-based recommendations for the use of IUDs in nulliparous women. Intrauterine devices are safe and effective for the majority of women including those who are nulliparous, and should be routinely included in the contraception options offered to them.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IUD; IUS; Intrauterine contraception; Intrauterine device; Intrauterine system; Nulliparous

Mesh:

Substances:

Year:  2016        PMID: 27591814     DOI: 10.1016/j.contraception.2016.08.011

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

Review 1.  Levonorgestrel IUD: is there a long-lasting effect on return to fertility?

Authors:  Erin Dinehart; Ruth B Lathi; Lusine Aghajanova
Journal:  J Assist Reprod Genet       Date:  2019-11-11       Impact factor: 3.412

2.  Determinants of Long-acting Reversible Contraception (LARC) Initial and Continued Use among Adolescents in the United States.

Authors:  C Emily Hendrick; Joshua N Cone; Jessica Cirullo; Julie Maslowsky
Journal:  Adolesc Res Rev       Date:  2019-07-12

Review 3.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

4.  Long-Acting Reversible Contraception: Placement, Continuation, and Removal Rates at an Inner-City Academic Medical Center Clinic.

Authors:  Aliye Runyan; Robert A Welch; Katherine J Kramer; Sarah Cortez; LeAnne J Roberts; Clementina Asamoah; Sarah Ottum; Jessica Sanders; Adib Shafi; Maurice-Andre Recanati
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

5.  Swiss gynecologists' opinions and perceptions concerning the use of intrauterine devices by nulliparous and multiparous women: an online survey study.

Authors:  Yaël Zimmermann; Manuela Viviano; Michal Yaron
Journal:  Int J Womens Health       Date:  2019-03-06

6.  A rodent model of human dose-equivalent progestin-only implantable contraception.

Authors:  Heather C M Allaway; Roger A Pierson; Jesse Invik; Susan A Bloomfield
Journal:  Reprod Biol Endocrinol       Date:  2021-03-22       Impact factor: 5.211

7.  Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology.

Authors:  Rossella Attini; Gianfranca Cabiddu; Benedetta Montersino; Linda Gammaro; Giuseppe Gernone; Gabriella Moroni; Domenico Santoro; Donatella Spotti; Bianca Masturzo; Isabella Bianca Gazzani; Guido Menato; Valentina Donvito; Anna Maria Paoletti; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2020-03-12       Impact factor: 3.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.